BUSTI, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 1385
EU - Europa 1283
AS - Asia 399
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 3081
Nazione #
US - Stati Uniti d'America 1380
GB - Regno Unito 542
CN - Cina 364
SE - Svezia 188
FR - Francia 152
IE - Irlanda 135
IT - Italia 87
FI - Finlandia 61
DE - Germania 53
UA - Ucraina 28
BE - Belgio 21
VN - Vietnam 19
AU - Australia 5
CA - Canada 5
RU - Federazione Russa 5
IN - India 4
ES - Italia 3
EU - Europa 3
IR - Iran 3
TR - Turchia 3
GR - Grecia 2
HK - Hong Kong 2
NL - Olanda 2
AR - Argentina 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
HR - Croazia 1
IQ - Iraq 1
MU - Mauritius 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 3081
Città #
Southend 491
Chandler 400
Jacksonville 232
Ann Arbor 164
Woodbridge 140
Dublin 133
Wilmington 67
Houston 64
Beijing 62
Lawrence 60
Princeton 60
Jinan 44
Nanjing 40
Ashburn 29
Verona 27
Shenyang 26
Lancaster 20
Redmond 20
Brussels 19
Haikou 19
Hebei 17
Zhengzhou 17
Falls Church 16
Ningbo 16
Nanchang 15
Redwood City 15
Tianjin 14
Changsha 12
Taizhou 11
Guangzhou 10
Jiaxing 10
Taiyuan 10
Fuzhou 8
Lanzhou 8
Milan 8
Norwalk 8
Fairfield 6
Hangzhou 6
San Francisco 6
Dong Ket 5
Nettuno 5
Chions 4
Düsseldorf 4
Toronto 4
Alexandria 3
Bangalore 3
Boardman 3
Helsinki 3
Los Angeles 3
New York 3
San Mateo 3
Berlin 2
Canberra 2
Central 2
Dearborn 2
Frankfurt am Main 2
Kish 2
Madrid 2
Mestre 2
Rome 2
San Diego 2
Taranto 2
Waanrode 2
Alpignano 1
Andover 1
Ardabil 1
Auburn Hills 1
Augusta 1
Austin 1
Boston 1
Brisbane 1
Cambridge 1
Carrù 1
Centurion 1
Changle 1
Chicago 1
Clearwater 1
Como 1
Cupertino 1
Des Moines 1
Fremont 1
Goldenstädt 1
Grafing 1
Hongtong 1
Islamabad 1
Laurel 1
London 1
Markham 1
Melbourne 1
Mondragone 1
Nagold 1
Nicosia 1
Novokuznetsk 1
Oklahoma City 1
Riva 1
Riyadh 1
Rocca Di Papa 1
Saint Louis 1
Salerno 1
Sarajevo 1
Totale 2434
Nome #
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 102
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 100
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 92
A time course of hepcidin response to iron challenge in HFE and TfR2 Haemochromatosis patients 87
A challenging case of abdominal pain associated to Helicobacter pylori infection 86
Paraoxonase-1 status in patients with hereditary hemochromatosis 86
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 86
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 81
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 80
DISHphagia: An Unusual Cause of Dysphagia. J Clin Endocrinol Metab. 79
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.c282y homozygous patients. 78
Identification of new BMP6 pro-peptide mutations in patients with iron overload 75
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 74
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 71
Hepcidin suppression relative to iron status in patients with chronic Hepatitits C 71
Altered paraoxonase expression in patients with genetic haemochromatosis. 70
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 69
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 67
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 66
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 65
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 65
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 65
Reduced serum hepcidin levels in patients with chronic hepatitis C 63
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 62
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 60
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 60
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 56
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 55
Paraoxonase-1 status in patients with hereditary hemochromatosis. 55
HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD. Preliminary reports from an ongoing study. 54
Anemia and adverse outcomes in the elderly: a detrimental inflammatory loop? 51
Iron deficiency in the elderly population, revisited in the hepcidin era. 49
Iron replacement therapy: entering the new era without misconceptions, but more research is needed 47
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 47
Modern iron replacement therapy: clinical and pathophysiological insights 45
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 41
Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis 40
Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist 40
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 39
An unusual case of inferior vena cava thrombosis: widening the differential diagnosis 38
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis 36
Iron replacement in inflammatory bowel disease: an evolving scenario 35
Anemia and iron deficiency in heart failure: extending evidences from chronic to acute setting 35
Practical implications of the 2019 Nobel Prize in Physiology or Medicine: from molecular adaptation to hypoxia to novel anti-anemic drugs in the clinic 34
COBALAMIN DEFICIENCY IN THE ELDERLY 34
Hyperferritinemia and diagnosis of type 1 Gaucher disease 30
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? 30
Impact of natural Neuromedin-B receptor variants on iron metabolism 29
Treatment options for anemia in the elderly 27
ERFE regulation in sickle cell disease: complex but promising 27
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 26
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 25
Iron metabolism in infections: Focus on COVID-19 25
Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19? 24
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 23
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 22
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information 20
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 19
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments 16
Hemochromatosis classification: update and recommendations by the BIOIRON Society 7
Recent Advancements in Hematology: Knowledge, Methods and Dissemination-1 7
Totale 3148
Categoria #
all - tutte 5827
article - articoli 4003
book - libri 0
conference - conferenze 1743
curatela - curatele 0
other - altro 81
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018263 0000 00 146102 9420
2018/2019209 117706 118 747 31011
2019/2020387 4110430 6336 3725 32502138
2020/2021446 20772349 8154 2018 11185025
2021/2022540 15164363 2223 729 201750127
2022/2023885 6813596200 103258 250 0000
Totale 3148